Byline: Melissa Rohman
-
Investigators to Explore Circadian Rhythms in Cancer and Aging
A team of Northwestern Medicine investigators led by Rina Fox, PhD, MPH, received a Cancer and Aging Translational Bridge Award to investigate circadian disruption in lymphoma.
-
Drug Demonstrates Poor Efficacy in Advanced Bladder Cancer
An FDA-approved monoclonal antibody drug used to treat advanced bladder cancer demonstrated poor efficacy in a recent clinical trial.
-
Second-Year PA Students Present Capstone Projects
Second-year students in the Physician Assistant (PA) Program presented their final capstone projects involving a comprehensive literature review of a clinical topic of their choosing during a virtual event on April 16.
-
Wayne and McDermott Honored for Contributions to Medical Education, Research
Diane B. Wayne, ’91 MD, and Mary McDermott, MD, ’92 GME, have been recognized by the Society of General Internal Medicine for their lifetime contributions to medical education and research.
-
Inaugural LEAP Program Graduates its First Class of Emerging Faculty Leaders
The Northwestern University Leadership Education Advancement Program (NU-LEAP) welcomed its inaugural class of Feinberg faculty graduates during a virtual ceremony on April 13.
-
Feinberg Welcomes Admitted Students During Virtual Second Look
Admitted students recently attended this year’s virtual Second Look, a month-long series of online informational sessions about the medical school’s curriculum and community and opportunities to speak with current students and faculty.
-
Understanding Epigenetic Regulators in Neurodevelopmental Diseases and Cancer
Northwestern Medicine investigators are advancing the understanding of two groups of transcription factors and their role in many neurodevelopmental diseases and cancers, which is essential for developing novel therapeutic approaches.
-
Study Discovers Dual Function of Neutrophils in Cancer Cells
Northwestern Medicine investigators have discovered how a particular type of immune cell exerts a dual function in cancer cells that is contingent on tumor grade.
-
PPA Conference Builds Connections in the Aphasia Field
More than 350 participants attended the Mesulam Center for Cognitive Neurology and Alzheimer’s Disease’s virtual PPA Conference, which featured keynote speakers and group support sessions focused on Primary Progressive Aphasia.
-
Protein Variant May Have Potential as Target for Glioblastoma
Inhibiting a novel protein variant within glioma stem cells may be a promising therapeutic approach to treat glioblastoma, according to a recent Northwestern Medicine study.
